Category: Rev.1 Updates
Medical Device Engineering Updates for 2022 and 2023
It’s been a year-and-a-half since we’ve expanded into our new Design & Innovation lab and Strategic Manufacturing site (Temecula and Murrieta, CA), geared towards first-of-kind medical device development and its early, flexible…...Read more
ASAHI INTECC AND REV.1 ENGINEERING® Support Medical Device Startups at AdvaMed and The MedTech Conference
Representatives from ASAHI INTECC and REV.1 Engineering were proud participants in this year’s combined AdvaMed and The MedTech Conference in Boston. REV.1 Engineering is a wholly owned subsidiary of ASAHI…...Read more
An Introduction To Strategic Manufacturing
Managing a medical device startup is not for the faint-of-heart. After moving heaven and earth to secure funding, you’re finally moving through your formal development process, sprinting towards V&V, animal…...Read more
Rev.1 Engineering® Announces Acquisition by ASAHI INTECC While Attending MD&M West
While attending MD&M West today, Rev.1 Engineering (Murrieta, CA) announced it has been acquired by ASAHI INTECC and will operate under ASAHI’s Solution Device Division (Filmecc). “As a Strategic Supplier…...Read more
Rev.1 Operations During COVID-19 Pandemic
As you have likely heard, the Governor of California has issued an Executive Order in response to the COVID-19 global pandemic. The California Department of Public Health has ordered all…...Read more
REV·1 Engineering® Launches New Website
World-class medical device design & development firm reformats website to support growing client base. REV.1 Engineering announced today the launch of their new website at https://rev1engineering.com. "Our clients are seeking solutions…...Read more
Rev.1 Engineering® Takes Early Phase Medical Device Development To The Next Level
It’s been a while since my last blog, as it’s been a busy summer here at REV·1 Engineering®. Things have been so busy, our team has grown by 30% since the…...Read more
Rev.1 Engineering® Named As Exclusive Development Partner For Valvublator
Leonhardt Ventures taps REV·1 Engineering to design and develop Valvublator's heart valve regeneration technology platform. REV·1 Engineering has been selected as the exclusive design and development partner for the commercialization…...Read more
Strategic Risk Management in Medical Device Development and Innovation
Employing Clinical Pathway Impact Analysis™ to drive efficacy at launch. While large medical device corporations have long looked to startups for new technologies and devices, there are additional, innovative benefits…...Read more
Rev.1 Engineering Medical Device Client Closes on $77 Million Series D Round
Ablative Solutions (Kalamazoo, MI) announces major investment in support of their innovative device technology intended for the treatment of hypertension. Rev.1 Engineering is pleased to announce one of their long-standing,…...Read more
Rev.1 Engineering Launches Development & Innovation Solutions
Celebrating its 10th year anniversary, Rev.1 Engineering is expanding to deliver comprehensive, strategic development and innovation solutions for its medical device and life science customers. Rev.1 Engineering announced today it…...Read more
10 Years of Innovation and Development
As 2017 winds to a close, we at REV.1 Engineering will be celebrating our 10th year in business. As this milestone approaches, we have been reflecting on our first decade…...Read more
Time to Market: 2x Faster with Rev.1 Engineering
REV.1 Engineering makes an astonishing claim: We can get you to market 2x Faster than building an in-house team. Whether you are a start-up in need of medical device R&D…...Read more
What to Expect: Medical Device Development with Rev.1 Engineering
Companies unfamiliar with using outsourced R&D for medical device development are often hesitant because they are uncertain about how the process should work. Here’s what to expect when you work…...Read more